{
    "2019-04-18": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Jim Cramer: Diversification Is Good for Offense, Not Just Defense",
                "features": {
                    "keywords": [
                        "diversification",
                        "offense",
                        "defense"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Pfizer, Lilly shares decline as osteoarthritis drug misses goals in study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Lilly",
                        "shares decline",
                        "drug misses goals"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study",
                "features": {
                    "keywords": [
                        "Pfizer-Lilly",
                        "painkiller",
                        "misses main goals",
                        "late stage study"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Novo Nordisk's (NVO) Share Price Rises YTD on Strong Pipeline",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "share price rises",
                        "strong pipeline"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}